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Aims We have investigated the effects of magnesium lithospermate B (MLB), the active compound of the Oriental herbal
remedy, Salvia miltiorrhizae, on endothelial dysfunction associated with diabetes mellitus using cultured endothelial
cells and an animal model of type 2 diabetes mellitus.
Methods
and results
The effect ofMLB on vasodilatory function inOtsuka Long-Evans Tokushima Fatty (OLETF) rats was assessed. MLB treat-
ment for 20 weeks starting at 12 weeks attenuated the decrease in endothelium-dependent vasodilation in OLETF rats.
MLB treatment also increased serumnitrite level and reduced serum advanced glycation end products concentration. The
effect ofMLBwas greater than anequivalent doseofa-lipoic acid (aLA), a popular antioxidant treatment.MLB rescued the
inhibition of endothelial nitric oxide synthase (eNOS) activity and eNOS phosphorylation in endothelial cells cultured in
hyperglycaemia. This effect was dependent on Akt phosphorylation and associated with decreased O-linkedN-acetylglu-
cosamine proteinmodification of eNOS.MLB also increased nuclear factor erythroid 2-related factor-2 (Nrf-2) activation
in a phosphoinositide3-kinase/Akt pathwaydependentmanner.MLB treatment induced the expressionof theNrf-2-regu-
lated antioxidant enzyme, heme oxygenase-1. The antioxidant aLA could not produce this effect. Moreover, MLB
decreased oxidative stress and endothelial cell apoptosis caused by hyperglycaemia.
Conclusion MLB is a naturally occurring, new generation antioxidant that activates eNOS and ameliorates endothelial dysfunction in
diabetes by enhancing vasodilation in addition to reducing oxidative stress. The relative strong performanceofMLBmakes
it an ideal candidate for further, expanded trials as a new generation of antioxidant to treat diabetes-related complications.
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1. Introduction
The vascular endothelium is of key importance in regulating blood
flow and tissue homeostasis. It is also the common target for all
risk factors linked to atherosclerosis and endothelial dysfunction
predicts future vascular problems. In diabetes mellitus, endothelial
vasodilator function becomes compromised and produces a proather-
osclerotic state. There is a strong correlation between alterations in
glucose metabolism and the development of coronary artery
disease, suggesting that atherosclerosis and diabetes possess similar
precursory events.1
Antioxidants have been tested as potential therapeutics for treating
vascular dysfunction in diabetes. However, despite a large number of
promising animal studies, the performance of antioxidants in large-scale
clinical trials has generally been disappointing.2 However, it is still too
early to discount the potential of antioxidant therapy as a treatment
for diabetes. Increases in our understanding of how oxidative stress is
generated in diabetes suggest that new antioxidants which suppress
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the generation of reactive species (in addition to merely scavenging free
radicals) can be important new therapeutic agents.
Traditional Chinese medicine can be a valuable source of new anti-
oxidants. Over 80 Chinese natural medicines have been documented
for the treatment of the secondary complications associated with dia-
betes.3 Most of these originate from plants and a small number orig-
inate from animals or insects. An attractive candidate antioxidant to
treat diabetes is magnesium lithospermate B (MLB). MLB is the
active component of the water soluble fraction of the Chinese medi-
cine, Danshen, which is a root preparation of the plant Red Sage
(salvia miltiorrhizae radix, ; related to lavender and oregano).4
MLB is an interesting antioxidant for further study because it has
interesting secondary effects in cells. MLB inhibits the enzyme
aldose reductase, which is a key component of the polyol biochemical
pathway involved in the pathogenesis of diabetic complications.5 Also,
the global market value of Danshen, an already popular herbal remedy
in North America, exceeds 2 billion US dollars.4
Previous research has shown that MLB has antifibrotic, myocardial
salvage, and neuroprotective effects.6 MLB prevents hepatitis, uraemia,
and improves blood circulation, arrhythmia, and renal function.7,8
Recent work in our laboratory showed that MLB can prevent the devel-
opment of neointimal hyperplasia in animal models of diabetes (H.C.L.,
unpublisheddata) and after balloon-induced injury.9However, the poten-
tial benefit of MLB on endothelial dysfunction in diabetes is unknown.
Thus, we assessed the effect of MLB on the consequences of endothelial
cell oxidative stress caused by hyperglycaemia [reactive oxygen species
(ROS) generation, apoptosis, glutathione (GSH) reduction, increased leu-
cocyte adhesion and advanced glycation end products (AGE) accumu-
lation]. We compared MLB with the widely studied antioxidant,
a-lipoic acid (aLA).10 In addition, we assessed the effect of MLB on
hyperglycaemia-induced inactivation of the enzyme endothelial nitric
oxide synthase (eNOS). eNOS catalyses the production of nitric oxide
(NO) from L-arginine. NO is widely considered to be the ‘antiathero-
genic’ molecule.11 The effect of MLB on hyperglycaemia-induced endo-
thelial dysfunction in vivo was measured in Otsuka Long-Evans
Tokushima Fatty (OLETF) rats, an animal model of diabetes.12
2. Methods
Expanded experimental detail and information concerning the purchase
of reagents and methods are described in the Supplementary material
online.
2.1 Cell culture
Human umbilical endothelial cells (HUVEC) and human aortic endothelial
cells (HAEC) were supplied by Cambrex (NJ, USA) and cultured in EBM-2
growthmedia supplementedwith the EGM-2 bullet kit. THP-1 humanmono-
cytic cells were cultured in RPMI-1640 medium supplemented with 0.05 nM
2-mercaptoethanol, 10% foetal bovine serum and antibiotics. Cells were cul-
tured in growthmedia containing 5 mMglucose for the normoglycaemia con-
dition or 30 mM glucose for the hyperglycaemia condition.
2.2 Measurement of cell proliferation
Cell proliferation was measured using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide, a tetrazole (MTT) assay, as previously
described.13
2.3 Measurement of ROS
The generation of ROS was determined analysing the oxidation of the
non-fluorescent dichlorofluorescein diacetate (DCF-DA) to the
fluorescent DCF. DCF emission was recorded using a fluorescence micro-
plate reader (SpectraMax GeminiEM, Molecular Devices) as previously
described.14
2.4 Glutathione assay
Glutathione and the disulfide dimer, glutathione disulfide, were measured
using the Glutathione Assay Kit II (Merck, NJ, USA). Cell lysate was har-
vested and a deproteination step was carried out using metaphosphoric
acid and triethanolamine (in accordance with the kit instructions).
2.5 Adhesion assay
The adhesion of mouse inflammatory peritoneal (IP) exudate macro-
phages to endothelial cell monlayers was carried out as previously
described.15 Briefly, endothelial cells were cultured to confluence in
six-well culture plates and treated with drug with or without high
glucose (30 mM) culture media. IP exudates macrophages (2 × 104 cells/
mL) were added to the monolayers and incubated for 20 min at 378C.
The unbound cells were washed three times and the total number of
adherent cells was counted in four randomly selected optical fields
per well.
2.6 Detection of apoptosis
Cells were cultured to confluence in 24-well plates and incubated with
according treatments. Cells were lysed and centrifuged at 200 g for 10 min.
Apoptosis was detected using the ‘Cell Death Detection ELISA Kit’ (Roche,
CA, USA), which is based on a quantitative sandwich-enzyme-immunoassay
principle, using mouse monoclonal antibodies directed against DNA and his-
tones released into the cytoplasm of cells that die from apoptosis.
2.7 Nitrite assay
Cells were cultured to confluence in 24-well plates. Total nitrite was
measured using the ParameterTM Total NO/Nitrate/Nitrite assay kit
(R&D Systems, MN, USA), in accordance with the manufacturer’s
instructions.
2.8 Measurement of AGE
Cells were cultured in 12-well plates. AGEwasmeasured by an ELISA based
on the method of Araki et al.16 2,2′-azino-bis(3-ethylbenzthiazoline-
6-sulphonic acid) (Sigma-Aldrich, SL, USA) was used as the detection
reagent. Purified human AGE was used to generate the standard curve.
2.9 Immnoprecipitation and western blot
analysis
For immunoprecipitation, the antibody/antigen complex was precipitated
using GammaBind Plus Sepharose (GE Healthcare, WI, USA.) in accord-
ance with the online protocol provided by Abcam, MA, USA. Proteins
were separated by 7.5% or 10% SDS–PAGE and transferred onto
PVDF membranes (Roth, Karlsruhe, Germany).
2.10 Immunocytochemical analysis of nuclear
factor erythroid 2-related factor-2
HAEC (1 × 105 cells/600 mL in a four-well chamber slide) were immunos-
tained with anti-nuclear factor erythroid 2-related factor-2 (Nrf-2)
primary antibody (Santa Cruz, CA, USA) followed by treatment with
FITC-goat anti-rabbit IgG secondary antibody. Stained cells were analysed
using a confocal microscope (Leica, NJ, USA).
2.11 Animals
OLETF rats and non-diabetic control Long-Evans Tokushima Otsuka
(LETO) rats were obtained from the Otsuka Pharmaceutical Company
(Tokushima, Japan). Animal studies were carried out under the guidelines
for the care and use of laboratory animals established by Yonsei University
College of Medicine; on the basis of the Guide for the Care and Use of
S.H. Kim et al.714
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Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996, PHS Approved Animal
Welfare Assurance code A5645-01).
2.12 Animal study
For studies of the effect of MLB on serum concentration of nitrite and
AGE, animals were divided into four groups of five rats at 12 weeks of
age: a control group (LETO), untreated diabetes group (OLETF), vehicle-
treated diabetes group (OLETF + vehicle), and MLB-treated diabetes
group (OLETF + MLB). MLB was dissolved in water and administered
orally to OLETF rats from 12 weeks of age, at a daily dose of 20 mg/kg,
via oral gavage which was shown to have beneficial systemic effects
without toxicity in previous studies.17,18 Vehicle-treated animals were
administered an identical volume of distilled water. Blood was collected
at baseline and at 4 and 8 weeks after commencing MLB treatment.
For vascular function studies, animals were divided into three groups of
eight rats at 12 weeks of age: a control group (LETO), vehicle-treated dia-
betes group (OLETF + Vehicle), and MLB-treated diabetes group
(OLETF + MLB). MLB was administered from 12 weeks of age, at a
daily dose of 20 mg/kg, via oral gavage. Oral glucose tolerance tests
were performed at the age of 29 weeks. At 32 weeks, the thoracic
aorta was isolated for vascular function studies.
Figure 1 (A) Chemical structure ofMLB (molecular weight ¼ 739). (B) Effect ofMLB oraLA treatment onROS generation inHAECexposed to hyper-
glycaemia (error ¼ SD; P, 0.05 for HG comparedwithNG (*), HG + 50 mMMLB comparedwith HG (#), andHG + 500 mMaLA comparedwith HG
(})]. Passage 5HAEC; data are representative of three independent experiments. (C)MLB treatment decreased theGSSG/GSH ratio inHAECexposed to
hyperglycaemia for 48 h (error ¼ SD; *P, 0.05 compared with NG; #P, 0.05 compared with HG). Treatment with 75 mM hydrogen peroxide for 3 h
was used as a positive control to induce oxidative stress. Data are representative of three independent experiments. (D) MLB treatment decreased leu-
cocyte adhesion to HAEC exposed to hyperglycaemia for 48 h (Error ¼ SD; *P, 0.05 compared with NG; #P, 0.05 compared with HG). Data are
representative of three independent experiments. (E) MLB inhibited apoptosis in HAEC exposed to hyperglycaemia for 48 h in a similar manner to
aLA. (Error ¼ SD; *P, 0.05 compared with NG; #P, 0.05 compared with HG). Data are representative of five independent experiments. Abbrevi-
ations: NG, 5 mM glucose; HG, 30 mM glucose; MLB, 50 mM magnesium lithospermate B; aLA, 500 mM alpha lipoic acid.
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2.13 Vascular function study
Endothelium-dependent and -independent vasorelaxation were measured
using an isometric force displacement transducer as described in the
online supplementary methods section.
2.14 Statistical analysis of data
For data sets with n ≤ 5, the Mann–Whitney U-test was used to deter-
mine significance. For data sets with n ≥ 5, one-way ANOVA (SPSS
12.0K software, IL, USA) was used to determine statistical significance,
employing Bonferonni corrections for multiple comparisons. A P-value
of ,0.05 was considered to be significant.
3. Results
3.1 MLB reduces ROS generation,
oxidative stress, apoptosis, and leucocyte
adhesion in human endothelial cells
exposed to hyperglycaemia
The structure of MLB is shown in Figure 1A. There are little published
data concerning the effects of MLB in endothelial cells. Therefore, we
tested the effect of MLB on cell proliferation in HAEC and HUVEC,
and compared MLB with aLA (see Supplementary material online,
Figure S1A and B). Treatment with MLB at a dose between 25 and
50 mM reduced proliferation in HAEC and HUVEC, in contrast to a
single published study.19 The effect of 50 mMMLB on cell proliferation
was similar to treatment with 500 mM aLA. However, treatment of
HAEC with 50 mM MLB for 48 h did not induce a significant increase
in cell death, as determined by flow cytometry (see Supplementary
material online, Figure S1C).
MLB reduced ROS generation in HAEC exposed to hyperglycaemia
after 1 day of treatment and continued to reduce ROS over a period
of 3 days (Figure 1B). The ability of MLB to reduce ROS generation
was concentration dependent. The effect of 50 mM MLB on ROS gen-
eration was similar to 62.5 mM MLB. Thus, 50 mM MLB treatment was
chosen for further study. The effect of 50 mM MLB on ROS gener-
ation was similar to treatment with 500 mM aLA. MLB also reduced
ROS generation in HUVEC exposed to hyperglycaemia for 3 days
(see Supplementary material online, Figure S2). HAEC exposed to
hyperglycaemia showed increased molar ratio of GSSG/GSH, indica-
tive of increased oxidative stress, and MLB treatment decreased the
ratio of GSSG/GSH (GSSG ¼ the oxidized form of GSH; Figure 1C).
The ability of 50 mM MLB to decrease the GSSG/GSH ratio in endo-
thelial cells exposed to hyperglycaemia was similar to 500 mM aLA.
Treatment with hydrogen peroxide was used as a positive control
for the induction of oxidative stress. Increased adhesion of leucocytes
to HAEC exposed to hyperglycaemia was inhibited by MLB treatment
(Figure 1D). A similar result was achieved in HUVEC (see Supplemen-
tary material online, Figure S3). The reduced adhesion was associated
with reduction in the expression of vascular adhesion molecule-1
(VCAM-1) after MLB treatment (see Supplementary material online,
Figure S4). VCAM-1 is a major intracellular binding molecule involved
Figure 2 (A) MLB inhibited the accumulation of AGE in HAEC cultured in hyperglycaemic media for 4 days. MTG and aminoguanidine (AG) were
used as a promoter and inhibitor of AGE formation, respectively [error ¼ SD. P, 0.05 after day 1 of treatment for HG compared with NG (*),
HG + 50 mM MLB compared with HG (#), HG + 500 mM aLA and HG + AG compared with HG]. Passage 5 HAEC; data are representative of
five independent experiments. (B) The ability of MLB to inhibit the accumulation of AGE in HAEC was visualized by immunoblotting. Data are repre-
sentative of three independent experiments. Abbreviations: NG, 5 mM glucose; HG, 30 mM glucose; MLB, 50 mM magnesium lithospermate B; aLA,
500 mM alpha lipoic acid; MTG, 200 mM methylglyoxal; AG, 10 mM aminoguanidine.
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Figure 3 (A) MLB rescued the decreased phosphorylation of eNOS at residue serine 1177 in HAEC exposed to hyperglycaemia for 48 h. PI 3-K signal-
ling pathway inhibitor LY-294,002 inhibited the effect of MLB on eNOS phosphorylation. Data are representative of three independent immunoblots.
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in monocyte binding to the vascular endothelium.20 The decrease in
VCAM-1 expression was partially linked to NO production,
because the eNOS inhibitor, L-NAME, could partially block this
effect. Moreover, apoptosis in HAEC exposed to hyperglycaemia
for 48 h was inhibited by MLB (Figure 1E). aLA treatment produced
a similar decrease in apoptosis.
3.2 MLB reduces AGE accumulation in
human endothelial cells exposed to
hyperglycaemia
AGE accumulation in vascular endothelial cells is an irreversible compli-
cation of hyperglycaemia and is linked to ‘metabolic memory’ in diabetic
patients.21 MLB reduced AGE accumulation in HAEC exposed to
hyperglycaemia after 1 day of treatment and continued to reduce
AGE accumulation for 4 days (Figure 2A). aLA treatment produced a
similar effect. Methylglyoxal (MTG) and aminoguanidine (AG) were
used as an inducer and inhibitor of AGE accumulation, respectively.
The ability of MLB to inhibit the AGE accumulation could be visualized
by western blotting (Figure 2B). MLB also inhibited AGE accumulation in
HUVEC (see Supplementary material online, Figure S5).
3.3 MLB increases eNOS phosphorylation
and activity in endothelial cells exposed to
hyperglycaemia: MLB acts through the
phosphoinositide 3-kinase/Akt intracellular
signalling pathway
Phosphorylation of residue serine 1177 is important in inducing eNOS
enzyme activity.22 MLB could inhibit the decrease in eNOS phosphoryl-
ation at residue serine 1177 in HAEC exposed to hyperglycaemia
(Figure 3A). In addition, the phosphoinositide 3-kinase (PI 3-K)/Akt intra-
cellular signalling pathway inhibitor LY-294,002 inhibited the effect of
MLB on eNOS phosphorylation. O-linked N-acetylglucosamine
(O-GlcNAc) modification of eNOS in diabetic subjects has also been
linked with reduced eNOS activity.23 MLB reduced the O-GlcNAc
modification of eNOS in HAEC exposed to hyperglycaemia
(Figure 3B). MLB increased NOS activity in HAEC exposed to hypergly-
caemia after 1 day of treatment and continuously over the 3 day time
course of the experiment (Figure 3C). aLA treatment produced a
similar effect. Two NOS specific inhibitors (L-NAME and 7-
nitroindazole) could inhibit MLB-induced increase in NOS activity in
HAEC exposed to hyperglycaemia. MLB also increased NOS activity
in HUVEC exposed to hyperglycaemia (see Supplementary material
online, Figure S6).
MLB treatment of HAEC increased the phosphorylation of Akt in
both normoglycaemic and hyperglycaemic conditions (Figure 3D).
Inhibition of the PI 3-K intracellular signalling pathway by
LY-294,002 inhibited the effect of MLB on NOS activity in HAEC
(Figure 3E), confirming the role of the PI 3-K/Akt intracellular signal-
ling pathway in mediating the effect of MLB. Previous data from our
laboratory have shown that treatment with MLB has no significant
effect on the mitogen-activated protein kinase (MAPK) pathway
(H.C.L., unpublished observations). Thus, we employed MAP kinase
inhibitors as a negative control when assessing the effect of MLB
on other intracellular signalling pathways. Accordingly, the MAPK
pathway inhibitor UO126 had no significant effect on NOS activity
(Figure 3E).
3.4 MLB acts through the PI 3-K/Akt
intracellular signalling pathway and the
Nrf-2 antioxidant response element
pathway in a sequential manner
Confocal microscopic analysis of HAEC showed that MLB promoted
Nrf-2 nuclear translocation (Figure 4A). This is a key step in the activation
of the antioxidant response element (ARE) pathway. In addition, inhi-
bition of the PI 3-K intracellular signalling pathway by LY-294,002 and
wortmannin reduced the nuclear accumulation of Nrf-2 in MLB-treated
HAECexposed to hyperglycaemia (Figure 4B). As a negative control, the
MAPK pathway inhibitor UO126 had no significant effect on Nrf-2
nuclear accumulation. MLB treatment could induce the expression of
a key target of the ARE pathway, heme oxygenase-1 (HO-1)
(Figure 4C). Treatment with other antioxidants (aLA and
N-acetyl-L-cysteine) could not produce this effect, confirming that acti-
vation of the ARE pathway is an important feature of MLB treatment.
3.5 MLB decreases AGE serum
concentration, increases serum nitrite,
and improves endothelium-dependent
vasodilatory function in OLETF
diabetic rats
Daily treatment with MLB for 8 weeks lowered serum AGE concen-
tration in OLETF diabetic rats (Figure 5A). In addition, daily treatment
Figure 3 continued
Densitometric intensity ratios are means SD (n ¼ 3) (#P, 0.05 compared with NG; }P, 0.05 compared with HG; *P, 0.05 compared with
HG + MLB). (B) MLB inhibited the increased O-GlcNAc glycosylation of eNOS in HAEC exposed to hyperglycaemia for 48 h (n ¼ 3)
(#P, 0.05 compared with NG; }P, 0.05 compared with HG). (C ) MLB increased total NO production in HAEC cultured in normoglycae-
mia. MLB also inhibited the decreased NO production in HAEC exposed to hyperglycaemia for 48 h. Two NOS inhibitors, L-NAME and 7-NI,
could inhibit the effect of MLB on NO production (error ¼ SD; after day 1 of treatment P, 0.05 for HG compared with NG, HG + 50 mM
MLB compared with HG, and HG + 500 mM aLA compared with HG). Passage 5 HAEC; data are representative of three independent exper-
iments. (D) MLB increased phosphorylation of Akt in HAEC exposed to hyperglycaemia for 48 h (n ¼ 3) (#P, 0.05 compared with NG;
}P, 0.05 compared with HG). (E) The PI 3-K signalling pathway inhibitor LY-294,002 reduced the ability of MLB to increase NOS activity
in HAEC exposed to hyperglycaemia. Treatment with the MAPK signalling pathway inhibitor UO126 had no significant effect on NOS activity.
Data are representative of three independent experiments (error ¼ SD; #P, 0.05 compared with NG; }P, 0.05 compared with HG;
*P, 0.05 compared with HG + MLB; ‡P, 0.05 compared with HG + MLB + LY). Abbreviations: NG, 5 mM glucose; HG, 30 mM
glucose; MLB, 50 mM magnesium lithospermate B; eNOS- ser 1177, eNOS phosphorylated at residue serine 1177; O-GlcNAc, O-linked
N-acetylglucosamine protein modification; L-NAME, 300 mM G-nitro-L-arginine-methyl ester; 7-NI, 900 nM 7-nitroindazole; UO, 10 mM
UO126; LY, 10 mM LY-294,002.
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with MLB increased serum nitrite levels (Figure 5B). MLB treatment
had no significant effect on body weight (Figure 5C) or glucose intol-
erance in OLETF rats compared with vehicle-treated rats (Figure 5D).
There was no difference in lipid profile or mean blood pressure in
MLB-treated OLETF rats compared with vehicle-treated rats (see
Supplementary material online, Table S1). MLB treatment significantly
improved endothelium-dependent vasodilatory function in OLETF
rats (Figure 5E). Endothelium-independent vasodilation was slightly
reduced in OLETF rats, but the MLB-treated rats showed no
significant difference compared with those treated with vehicle
(Figure 5F ).
4. Discussion
The research study presented herein aimed to investigate the effect of
MLB treatment on hyperglycaemia-induced endothelial dysfunction in
vitro and in an animal model of diabetes. We measured the effect of
MLB on a number of consequences of hyperglycaemia-induced oxi-
dative stress and compared its effects with the antioxidant, aLA.
aLA was chosen for comparative study because: (i) aLA has been
studied extensively, (ii) aLA exerts its effects in both aqueous and
lipid environments, and (iii) it is an approved treatment for compli-
cations in diabetes.10 The effect of MLB on eNOS activity was
Figure 4 (A) 48 h MLB treatment of HAEC cultured in normoglycaemia induced the nuclear translocation of Nrf-2. HAEC cultured in hypergly-
caemia or HG + 50 mM MLB also showed increased nuclear translocation of Nrf-2 (Bar ¼ 20 mm). (B) Nuclear translocation of Nrf-2 in HAEC
treated with MLB for 48 h was inhibited by treatment with the PI 3-K signalling pathway inhibitors LY and WO. The MAPK signalling pathway inhibitor
UO126 had no significant effect on nuclear translocation. Passage 5 HAEC. Data are representative of three independent immunoblots. Densitometric
intensity ratios are means+ SD (n ¼ 3; #P, 0.05 compared with HG + MLB). (C ) Treatment with MLB can induce the expression of the antioxidant
enzyme, HO-1. The antioxidants aLA and N-acetyl-L-cysteine could not produce this effect (n ¼ 3; *P, 0.05 compared with HG; #P, 0.05 com-
pared with HG + MLB). Abbreviations: NG, 5 mM glucose; HG, 30 mM glucose; MLB, 50 mM magnesium lithospermate B; UO, 10 mM UO126;
WO, 100 nM wortmannin; LY, 10 mM LY-294,002; aLA, 500 mM alpha lipoic acid; NAC, 1 mM N-acetyl-L-cysteine; PI, propidium iodide nuclear
marker.
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tested because this enzyme is an important producer of NO; a pivotal
inducer of vasodilation that has a large number of beneficial effects on
endothelial integrity.11 The OLETF type II diabetic rat was chosen as
an animal model to study the effect of MLB treatment because the
most prevalent form of diabetes mellitus is type II and these rats
display hyperinsulinaemia, hyperglycaemia, insulin resistance, hypertri-
glycaemia, and mild obesity.12
This is the first study to show that MLB treatment has beneficial
effects on endothelial cell dysfunction induced by hyperglycaemia.
MLB performed as well as aLA at a 10-fold lower dose. We
showed that MLB produced its beneficial effect by stimulating the PI
3-K signalling pathway, which phosphorylates Akt. Akt phosphorylates
eNOS and increases the production of NO. MLB treatment of dia-
betic rats increased serum NO and decreased serum accumulation
of AGE. These data are valuable because there are relatively little pub-
lished data concerning serum NO and, especially, serum AGE, in dia-
betic animals treated with antioxidants. It should be noted that MLB
also increased NOS activity in cells cultured in normoglycaemia,
suggesting that constitutively expressed eNOS mediates the beneficial
effect of MLB. Moreover, this study showed that MLB increased
Figure 5 (A) MLB treatment lowered serum AGE concentration in OLETF diabetic rats. Rats were administered MLB or vehicle (distilled water) daily
from 12 weeks of age (day 0 of treatment). Serum AGE accumulation was significantly reduced after 8 weeks of treatment with MLB (error ¼ SD;
#P, 0.05 compared with LETO non-diabetic rats; }P, 0.05 compared with OLETF treated with vehicle). (B) MLB treatment increased serum nitrite
levels in OLETF diabetic rats. Rats were administered MLB or vehicle (distilled water) daily from 12 weeks of age (day 0 of treatment). Serum nitrite
level was significantly increased at both 4 and 8 weeks of treatment with MLB (error ¼ SD; #P, 0.05 compared with LETO non-diabetic rats;
}P, 0.05 comparedwithOLETF treatedwith vehicle). (C)Mean change in bodyweight over 17weeks of treatmentwithMLB. Bodyweightwasmeasured
weekly. (D) Blood glucose concentration at 29 weeks; after 17 weeks of MLB treatment. (E) Effect of MLB treatment on endothelium-dependent vaso-
dilatory function in OLETF diabetic rats, in response to acetylcholine after phenylephrine preconstriction of aortic segments. (F ) Effect of MLB treatment
on endothelium-independent vasodilatory function inOLETF diabetic rats, in response to sodium nitroprusside in phenylephrine-precontstricted vessels.
Data are expressed as mean+ SD (n ¼ 8 per group). *P, 0.05 vs. LETO group; #P, 0.05 vs. vehicle-treated OLETF group.
S.H. Kim et al.720
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on D
ecem
ber 22, 2013
http://cardiovascres.oxfordjournals.org/
D
ow
nloaded from
 
eNOS phosporylation at residue serine 1177. Previous reports
suggest that serine 1177 phosphorylation alone is the major regulator
of eNOS activity in hyperglycaemic conditions.24 MLB-induced eNOS
phosphorylation was associated with decreased O-GlcNAc protein
modification of eNOS. Hyperglycaemia induces overproduction of
superoxide by the mitochondria and results in hexosamine pathway
activation. It has been shown that hyperglycaemia inhibited eNOS
activity in cultured bovine aortic endothelial cells by activating the
hexosamine pathway via mitochondrial overproduction of superoxide,
which increases eNOS modification by O-GlcNAc and decreases
eNOS serine phosphorylation in a reciprocal manner.24 The recipro-
cal modification was reported to occur specifically at Ser1177, the
Akt phsophorylation site responsible for the activation of eNOS.22
MLB was shown to activate the PI 3-K/Akt and ARE pathways in
endothelial cells. This activity is similar to that reported for the antiox-
idant, tert-butylhydroquinone (tBHQ). A previous study reported a
beneficial effect of tBHQ treatment in a model of diabetes.25
However, in contrast to MLB, tBHQ treatment has also been linked
to DNA damage and carcinogenesis. Moreover, MLB-treated rats had
favourable blood pressure measurements, which would be consistent
with an absence of endothelial cytotoxicity associated with long-term
ingestion of MLB. MLB-treated OLETF rats also had improved
endothelium-dependent vasodilation response to acetylcholine
compared with the placebo treated OLETF rats, suggesting a low prob-
ability of cytotoxicity and an intact endothelium. In addition, a previous
study on the effect of MLB on the development of diabetic in OLETF
rats17 employed a dose of 20 mg/kg LAB for 28 weeks, starting at
10 weeks, and there were no toxicity observed in the animals.
However, in-depth investigation of potential MLB-mediated endothelial
toxicity in higher doses in vivo could be an area of future study.
There is a pressing need to develop a new generation of antioxidant
based therapies for treating complications in diabetes.26 Treatment
with ‘traditional’ antioxidants, such as vitamin C and vitamin E, has
recently been suggested to be detrimental by blocking exercise
induced decreases in insulin resistance.27 MLB represents a new gen-
eration of antioxidants that possess additional beneficial effects in
addition to ROS scavenging activity. MLB can inhibit the enzyme
aldose reductase, which is a key component of the polyol pathway.5
In addition, this study has shown that MLB can also activate the PI
3-K signalling pathway and ARE pathway in endothelial cells, producing
an increased expression of the antioxidant enzyme, HO-1. The anti-
oxidants aLA and NAC could not produce this effect. This is an
important finding, because targeting the Nrf-2 defence pathway in car-
diovascular disease is currently an important focus of research.28
Moreover, this study has shown that MLB enhanced endothelium-
dependent relaxation in diabetic rats to a similar degree as reported
for aLA.10 These additional features make MLB an attractive candidate
agent for future clinical trials in diabetic subjects. A schematic diagram
showing the proposed mechanisms by which MLB can prevent endo-
thelial dysfunction resulting from hyperglycaemia is shown in Figure 6.
Recent diabetes research has developed the concept of ‘molecular
memory’, which is the long-term influence of early metabolic control
on clinical outcomes such as diabetic complications. Specific long-lasting
epigenetic changes induced by ROS and AGE formation (irreversible,
non-enzymatic protein modifications that generate inflammatory
cytokines and growth factors) are both implicated in the mechanism
of molecular memory.21 Therefore, MLB may become an ideal
therapeutic for preventing or delaying the onset of diabetic
complications.
Nevertheless, a number of questions remain unanswered about the
biochemical action of MLB. The chemical structure of MLB comprises
a repeating motif that makes modification of this molecule, such as
biotinylation, difficult without abrogating activity (H.C.L., unpublished
data). Moreover, microarray analysis of the effect of MLB in cells sus-
ceptible to hyperglycaemia-induced damage only confirmed the invol-
vement of the ARE pathway, without giving clues about the actual
molecular target(s) (H.C.L., unpublished data). Thus, further study is
required to provide further clues about the molecular target(s) of
MLB. Moreover, extracts from the plant salvia miltiorrhizae radix
contain other active compounds in addition to MLB.29 Combination
therapy with these additional active compounds may further
enhance the therapeutic effect of MLB. Thus, MLB possesses many
attractive characteristics for future study.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
Conflict of interest: none declared.
Figure 6 Schematic representation of the effects of MLB to block
hyperglycaemia-induced vascular endothelial dysfunction. The data
presented in this study have shown that MLB treatment can counter-
act the decrease in the activity of the PI 3-K/Akt pathway, leading to
the activation of the Nrf-2 ARE pathway and activation of the PI 3-K/
Akt/eNOS pathway in endothelial cells. We have also shown that
MLB treatment can block four consequences of endothelial cell
exposure to hyperglycaemia (increase in AGE formation, increase
in oxidative stress, increase in hexosamine pathway and reduction
in vascular function).
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